Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

(CTN News) – According to a statement that was released by Novavax on Wednesday, it appears that the Food and Drug ...

Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

As FDA Delays Novavax' COVID Vaccine Approval, Patients Fight Back By Julie ... approval – which rival mRNA shots from Moderna and Pfizer and its partner BioNTech already have - was due from ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

A decision on full approval – which rival mRNA shots from Moderna and Pfizer and its partner ... the company got word that the FDA would consider approving the vaccine, provided Novavax agrees ...

Novavax had anticipated full approval of its vaccine by April 1, but the FDA delayed the decision because ... than the newer mRNA vaccines from Pfizer/BioNTech and Moderna, has been subject ...